Drug Profile


Alternative Names: RGH 5002; SILA 336

Latest Information Update: 08 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gedeon Richter
  • Class Antiparkinsonians; Muscle relaxants; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Muscle hypertonia

Most Recent Events

  • 08 Nov 2006 Discontinued - Phase-II for Hypertonia in Hungary (unspecified route)
  • 17 Aug 1998 RGH 5002 is now called silperisone
  • 17 Aug 1998 Phase-II clinical trials for Hypertonia in Hungary (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top